Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet

Vildagliptin is a potent and selective inhibitor of dipeptidyl peptidase-IV (DPP-4), orally active, that improves glycemic control in patients with type 2 diabetes (T2DM) primarily by enhancing pancreatic (α and β) islet function. Thus vildagliptin has been shown both to improve insulin secretion an...

Descripción completa

Detalles Bibliográficos
Autores principales: Halimi, Serge, Schweizer, Anja, Minic, Biljana, Foley, James, Dejager, Sylvie
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515409/
https://www.ncbi.nlm.nih.gov/pubmed/18827867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515409/
https://www.ncbi.nlm.nih.gov/pubmed/18827867

Ejemplares similares